Lori Brisbin-Ferraro

Lori Brisbin-Ferraro has held various key roles in the healthcare industry. Lori served as the VP Precision Medicine at Texas Oncology since 2018. Prior to that, they were the Chief Commercial Officer at med fusion from 2014 to 2018, where they managed commercial laboratory business operations. Lori also worked as the Vice President of Commercial Operations at Caris Life Sciences from 2011 to 2014, overseeing sales and product development. Lori'scareer also includes roles at Asuragen, BD, Roche, and Digene Corporation, where they contributed to sales, marketing, and scientific research.

Lori Brisbin-Ferraro completed their undergraduate studies in molecular biology and chemistry at the University of Maryland from 1988 to 1990. Lori then obtained their Master of Science degree in Molecular Biology from Syracuse University from 1990 to 1992.